Morse Asset Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$80.7K Buy
812
+126
+18% +$16.4K 0.02% 198
2025
Q4
$83.5K Buy
+686
New +$86.1K 0.02% 186
2025
Q1
Sell
-50
Closed -$3.12K 379
2024
Q4
$3.12K Sell
50
-5,191
-99% -$483K ﹤0.01% 286
2024
Q3
$823K Buy
+5,241
New +$808K 0.18% 102

Other funds holding TMDX

Morse Asset Management's TMDX Position: Q1 2026 in Review

Morse Asset Management increased its Transmedics (TMDX) stake by 18% in Q1 2026, buying an estimated $16.4K and bringing the position to 812 shares worth $80.7K. The position accounts for 0.02% of the portfolio, ranked #198.

Morse Asset Management first reported a position in TMDX in Q3 2024 and has held it in 4 quarters since. The position peaked at $823K in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Morse Asset Management held 812 shares of Transmedics worth $80.7K as of Q1 2026.
  • Morse Asset Management bought 126 Transmedics shares in Q1 2026, an estimated $16.4K.
  • Transmedics made up 0.02% of Morse Asset Management's portfolio in Q1 2026, its #198 holding.
  • Morse Asset Management first reported a position in Transmedics in Q3 2024 and has held it in 4 quarters since.
  • Morse Asset Management's Transmedics position peaked at $823K in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Morse Asset Management's 13F filing for Q1 2026, filed 14 May 2026.